Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.

Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.

Item
http://www.wikidata.org/entity/Q35882920
Profile of romosozumab and its potential in the management of osteoporosis.Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys.Old age and the associated impairment of bones' adaptation to loading are associated with transcriptomic changes in cellular metabolism, cell-matrix interactions and the cell cycle.Epigenetics and Bone Remodeling.Fracture healing physiology and the quest for therapies for delayed healing and nonunion.Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts.One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.Bone CLARITY: Clearing, imaging, and computational analysis of osteoprogenitors within intact bone marrow.Sclerostin Antibody Treatment Enhances Rotator Cuff Tendon-to-Bone Healing in an Animal Model.Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.Bone-Targeted Therapies in Cancer-Induced Bone Disease.Laser Capture Microdissection and Transcriptional Analysis of Sub-Populations of the Osteoblast Lineage from Undecalcified Bone.Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats.Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody.Anabolic Strategies to Augment Bone Fracture Healing.Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
P2860

Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.

Item
http://www.wikidata.org/entity/Q35882920
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@ast
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@en
type
label
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@ast
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@en
prefLabel
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@ast
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P5875
P698
P921
P356
P1433
P1476
Time-dependent cellular and tr ...... atment in ovariectomized rats.
@en
P2093
P304
P31
P356
10.1016/J.BONE.2015.12.013
P478
P577
P5875
P698
P921